Valuation (72%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 13.56 | N/A |
| PEG Ratio (TTM) | -1.88 | N/A |
| P/S Ratio (TTM) | 1.87 | N/A |
| P/B Ratio (TTM) | 0.90 | N/A |
| P/FCF Ratio (TTM) | 11.47 | N/A |
| Price to 5YR AVG Earnings Ratio | 11.37 | N/A |
| Price to 5YR AVG FCF Ratio | 11.39 | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.76% | N/A |
| ROE (TTM) | 6.90% | N/A |
| Net Profit Margin (TTM) | 13.76% | N/A |
| ROIC 5YR AVG | 9.57% | N/A |
Growth (80%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 1.40% | 54.16% | 23.25% |
| Revenue | 6.77% | 13.87% | 12.72% |
| Net Income | 1.29% | 56.82% | 29.36% |
| Cash Flow | 48.94% | 6,371.23% | 3,817.56% |
Health (47%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.12 | N/A |
| Quick Ratio (TTM) | 0.12 | N/A |
| D/E Ratio (TTM) | 0.17 | N/A |
| Interest Coverage (TTM) | 0.53 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 0.10 | N/A |
| LTL to 5YR AVG FCF | 2.23 | N/A |
| Shares Outstanding Growth 5YR AVG | 7.19% | N/A |